Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Schweizer Archiv Fur Tierheilkunde|October 7, 2016
Unexplained bleeding as primary clinical complaint in dogs infected with Angiostrongylus vasorumT Glaus, N Sigrist, N Hofer-Inteeworn, et al.
Neurology|June 10, 2010
Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MSA T Reder, G C Ebers, A Traboulsee, et al.
Neurology|November 28, 2001
Interferon-beta1b in the treatment of secondary progressive MS: impact on quality of lifeJ A Freeman, A J Thompson, R Fitzpatrick, et al.
Journal of Neurology|May 17, 2005
Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of interferon beta-1b in patients with secondary progressive multiple sclerosisPeter Rieckmann, N Kruse, L Nagelkerken, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 22, 2010
Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trialG C Ebers, A Traboulsee, D Li, et al.
Dalton Transactions (Cambridge, England : 2003)|August 30, 2012
Synthesis, characterization, DFT studies and catalytic activities of manganese(II) complex with 1,4-bis(2,2':6,2''-terpyridin-4'-yl) benzeneM M Najafpour, W Hillier, A N Shamkhali, et al.
European Neurology|January 25, 2014
Effects of inhibitors of the renin-angiotensin system on the efficacy of interferon beta-1b: a post hoc analysis of the BEYOND studyM Doerner, K Beckmann, V Knappertz, et al.
Neurology|April 13, 2012
Survival in MS: a randomized cohort study 21 years after the start of the pivotal IFNβ-1b trialD S Goodin, A T Reder, G C Ebers, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 10, 2008
Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosisI J van den Elskamp, J Lembcke, V Dattola, et al.
Prostate Cancer and Prostatic Diseases|June 7, 2017
Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: a systematic review of prognostic accuracy and validityM E O'Callaghan, E Raymond, J Campbell, et al.
Pageof 5